Clinical trial of malaria prophylaxis in tropical splenomegaly syndrome.
A controlled, randomized, double-blind trial of malaria prophylaxis in tropical splenomegaly syndrome showed a significant reduction in spleen size and an improvement of anaemia and symptoms in patients treated with antimalarials compared with control subjects receiving placebo. This study confirms the observations from West Africa and provides further indirect evidence for a malarial aetiology of tropical splenomegaly syndrome.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy; D001706:Biopsy; D002648:Child; D002738:Chloroquine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans
D002738:Chloroquine